4
Changes in Ownership
agilon health, inc. Filed Acc 0001209191-22-025550
Chief Strategy & Dev. Officer sold 106,357 shares at an average $20.40 ($2,169,952)
- Chief Strategy & Dev. Officer acquired 106,357 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Desai Veeral · Chief Strategy & Dev. Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-04-21 | Exercise or conversion : show line 1 in the form | +79,568 | $1.00 | $79,568 | 357,779 | D |
| 2022-04-21 | Sale : show line 2 in the form | −69,824 | $20.43 | $1,426,183 | 287,955 | D |
| 2022-04-21 | Sale : show line 3 in the form | −9,744 | $21.35 | $207,989 | 278,211 | D |
| 2022-04-22 | Exercise or conversion : show line 4 in the form | +26,789 | $1.00 | $26,789 | 305,000 | D |
| 2022-04-22 | Sale : show line 5 in the form | −26,789 | $20.00 | $535,780 | 278,211 | D |
| Open-market sales · 106,357 sh · avg $20.40 · $2,169,952 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-04-21 | Exercise or conversion : show line 6 in the form Options (Rights to Buy) | −79,568 | 589,426 | D |
| 2022-04-22 | Exercise or conversion : show line 7 in the form Options (Rights to Buy) | −26,789 | 562,637 | D |
Loading xslF345X03/doc4.xml…